LAURUS LABS
Back to Cashflow Statement
|
LAURUS LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,624 Cr | ₹602 Cr | ₹666 Cr | ₹994 Cr | ₹911 Cr |
What is the latest Cash Flow from Operating Activities ratio of LAURUS LABS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,624 Cr |
| Mar2025 | ₹602 Cr |
| Mar2024 | ₹666 Cr |
| Mar2023 | ₹994 Cr |
| Mar2022 | ₹911 Cr |
How is Cash Flow from Operating Activities of LAURUS LABS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,624 Cr | 169.84 | |
| Mar2025 | ₹602 Cr | -9.62 | |
| Mar2024 | ₹666 Cr | -33.02 | |
| Mar2023 | ₹994 Cr | 9.09 | |
| Mar2022 | ₹911 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹106,114.9 Cr | -2.4% | 5.4% | 138.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | -2.4% |
5.4% |
138.9% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses